Spastic quadriplegia in Down syndrome with congenital duodenal stenosis/atresia

Congenit Anom (Kyoto). 2012 Jun;52(2):78-81. doi: 10.1111/j.1741-4520.2012.00357.x.

Abstract

Down syndrome is an autosomal chromosome disorder, characterized by intellectual disability and muscle hypotonia. Muscle hypotonia is observed from neonates to adulthood in Down syndrome patients, but muscle hypertonicity is extremely unusual in this syndrome. During a study period of nine years, we found three patients with severe spastic quadriplegia among 20 cases with Down syndrome and congenital duodenal stenosis/atresia (3/20). However, we could find no patient with spastic quadriplegia among 644 cases with Down syndrome without congenital duodenal stenosis/atresia during the same period (0/644, P < 0.05). Further, we did not find any cases with spastic quadriplegia among 17 patients with congenital duodenal stenosis/atresia without Down syndrome admitted during the same period to use as a control group (0/17, P < 0.05). Our results suggest that congenital duodenal stenosis/atresia is a potential risk factor for spastic quadriplegia in patients with Down syndrome. Long-term survival is improving, and the large majority of people with Down syndrome are expected to live well into adult life. Management and further study for the various problems, representing a low prevalence but serious and specific to patients with Down syndrome, are required to improve their quality of life.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / diagnosis
  • Brain / pathology
  • Child, Preschool
  • Down Syndrome / complications*
  • Down Syndrome / diagnosis
  • Duodenal Obstruction / congenital*
  • Duodenal Obstruction / diagnosis
  • Duodenal Obstruction / therapy
  • Female
  • Humans
  • Infant
  • Intestinal Atresia* / diagnosis
  • Intestinal Atresia* / therapy
  • Magnetic Resonance Imaging
  • Male
  • Quadriplegia / complications*
  • Quadriplegia / diagnosis
  • Quadriplegia / drug therapy